Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Rtw Biotech (RTW)

Price $1.32 on 02-05-2024 at 17:38:02
Change $0.02 1.54%
Buy $1.33
Sell $1.31
Buy / Sell RTW Shares
Last Trade: Unknown 100,000.00 at $1.32
Day's Volume: 1,820,487
Last Close: $1.32
Open: $1.30
ISIN: GG00BKTRRM22
Day's Range $1.30 - $1.32
52wk Range: $1.05 - $1.43
Market Capitalisation: $508m
VWAP: $1.317574
Shares in Issue: 385m

Recent Trades History Rtw Biotech (RTW)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 100,000 $1.32 Negotiated Trade
15:38:02 - 02-May-24
Unknown* 250,000 $1.3175 Ordinary
12:53:33 - 02-May-24
Unknown* 250,000 $1.3175 Ordinary
13:02:08 - 02-May-24
Unknown* 250,000 $1.3175 Ordinary
13:02:19 - 02-May-24
Unknown* 250,000 $1.3175 Ordinary
12:53:23 - 02-May-24
Unknown* 250,000 $1.3175 Ordinary
12:53:26 - 02-May-24
Unknown* 250,000 $1.3175 Ordinary
12:53:29 - 02-May-24
Buy* 24,000 $1.32 Automatic Execution
15:26:06 - 02-May-24
Sell* 799 $1.31 Automatic Execution
15:25:41 - 02-May-24
Sell* 180 $1.31 Automatic Execution
15:25:37 - 02-May-24

Share Price History for Rtw Biotech

Time period:
to
Date Open High Low Close Volume

Share News for Rtw Biotech

RTW Biotech invests in cell and gene therapy company Obsidian

5th Apr 2024 12:14

(Alliance News) - RTW Biotech Opportunities Ltd on Friday said it has backed cell and gene therapy-focused biotech Obsidian Therapeutics Inc. Read More

EARNINGS: EPE Special "cautiously optimistic"; RTW Biotech NAV rises

2nd Apr 2024 11:15

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Franchise Brands sets targets, Cindrigo agrees loan

20th Feb 2024 20:13

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: RTW Biotech Opportunities NAV increases 2.5% in January

14th Feb 2024 19:53

RTW Biotech Opportunities Ltd - London-based venture capital firm focused on biotechnology companies - Says net asset value per share at January 31 was USD1.94, up 2.5% from USD1.90 the previous month. Notes that this NAV does not reflect the completion of the Arix Bioscience PLC transaction. RTW intends to publish, at the soonest opportunity, an indicative and estimated pro forma NAV and NAV per share reflecting the completion of the transaction and new share issuance. In January, RTW said it completed its previously announced acquisition of a 25.5% stake in Arix Bioscience PLC for USD57.1 million, equivalent to GBP1.37 per Arix share. Purchase is to support its planned all-share acquisition of Arix's assets. Read More

TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up

12th Feb 2024 19:44

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

FTSE 100 Latest
Value8,172.15
Change50.91

Login to your account

Forgot Password?

Not Registered